Roger Hesselstrand
51 – 60 of 172
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice : A prospective cohort study
- Contribution to journal › Article
-
Mark
Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
- Contribution to journal › Article
-
Mark
CMR feature tracking in cardiac asymptomatic systemic sclerosis : Clinical implications
- Contribution to journal › Article
-
Mark
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
- Contribution to journal › Article
- 2018
-
Mark
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
- Contribution to journal › Article
-
Mark
Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension
- Contribution to journal › Article
-
Mark
The assessment of nailfold capillaries : Comparison of dermoscopy and nailfold videocapillaroscopy
- Contribution to journal › Letter
-
Mark
Gender differences in early systemic sclerosis patients : a report from the EULAR scleroderma trials and research group (EUSTAR) database
- Contribution to journal › Article
-
Mark
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study
- Contribution to journal › Article
